ImmuCell(ICCC) - 2024 Q2 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 001-12934 (Commission file number) ImmuCell Corporation (Exact name of registrant as specified in its charter) (StateofIncorporation) 56 Evergreen Drive, Portland, ME (Address of principal executive office) | --- | --- | |----------------|-------| | | | | | | | | | | | | | | | | | | | | | | (I. ...